October 30, 2008
ACE Vision Group, Inc. Announces New Global Medical Director, Dr. Marguerite McDonald
SILVER LAKE, Ohio, Oct. 30 /PRNewswire/ -- ACE Vision Group, Inc. today announced the appointment of Marguerite McDonald, M.D. as Global Medical Director. Dr. McDonald is a cornea/refractive/anterior segment specialist for Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan and an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.
Dr. McDonald is a staff physician at Manhattan Eye, Ear and Throat Hospital in New York City, as well as at the Island Eye Center in Carle Place, New York. Dr. McDonald received her medical degree from Columbia University College of Physicians and Surgeons, followed by an internship at Lenox Hill Hospital and ophthalmology residency at Manhattan Eye, Ear and Throat Hospital/Cornell, both in New York City, and a fellowship in corneal and external diseases with Dr. Herbert E. Kaufman at the LSU Eye Center in New Orleans.
Dr. McDonald has been honored by selection to the editorial boards of several publications, including the Journal of Cataract and Refractive Surgery and Refractive and Corneal Surgery. In 1997 she was elected to the Executive Committee of the prestigious American Society of Cataract and Refractive Surgery (ASCRS), and was elected its first female president for the 2002-2003 term. Dr. McDonald is the president for the 2008-2010 term of the International Society of Refractive Surgery of the American Academy of Ophthalmology, the largest refractive surgery society in the world; she is the first female president of this organization.
ACE Vision Group, Inc. President & CEO Patrick H. Witham stated: "In Dr. McDonald, ACE is adding a highly-skilled, top-notch industry leader to further strengthen our clinical team. It is her unprecedented level of expertise that makes her an ideal fit for ACE Vision Group as we work diligently to successfully advance this technology through clinical development and toward the market."
ACE Vision Group, Inc. Chief Scientific Officer Dr. AnnMarie Hipsley commented: "Marguerite has an amazing wealth of knowledge and depth of experience as a liaison between the FDA and companies delivering innovative technology. I am confident that her participation will be a catalyst to the great success that lays ahead for AVG."
About ACE Vision Group, Inc.
Headquartered in Silver Lake, Ohio, and a branch office in Eugene, Oregon, ACE Vision Group Inc. is an ophthalmic medical device company that was established in 2006 to develop and market proprietary technology to restore dynamic accommodation in an aging eye for patients seeking to reduce or eliminate their dependency on reading glasses. More information: http://www.acevisiongroup.com/.
*(LOGO 72dpi: Send2Press.com/mediaboom/08-1030-AceVis_72dpi.jpg)
For more information about ACE Vision Group, Inc. call AVG Public Relations at (866) 596-2188 or email: [email protected]
This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.send2press.com/
ACE Vision Group, Inc.
CONTACT: Carrie Casey of ACE Vision Group, Inc., +1-541-762-1504,[email protected]
Web site: http://www.acevisiongroup.com/